Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids; D001794:Blood Pressure / Q000187:drug effects; D003645:Death, Sudden / Q000209:etiology*; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000037:antagonists & inhibitors*; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011460:Prostaglandins F / Q000096:biosynthesis; D011651:Pulmonary Artery / Q000473:pathology; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D013928:Thromboxane A2 / Q000494:pharmacology; D013929:Thromboxane B2 / Q000097:blood; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D001095:Arachidonic Acids; D007093:Imidazoles; D011460:Prostaglandins F; D014662:Vasoconstrictor Agents; C029166:dazoxiben; D016718:Arachidonic Acid; D012701:Serotonin; D013929:Thromboxane B2; D013928:Thromboxane A2; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase